抗血栓药,由于心脑血管疾病的发病率增加和人口老龄化,包括抗血小板剂和抗凝剂在韩国被广泛使用。在内镜手术期间使用抗血栓药物的患者管理是一个重要的临床挑战。由韩国胃肠内窥镜学会制定的有关此问题的临床实践指南于2020年发布。然而,从那以后,出现了双重抗血小板治疗和直接抗凝治疗的新证据,修订后的指南在美国和欧洲发布。因此,修订了以前的准则,心脏病学家也参加了发展小组,这些建议经过了国际专家的共识过程。本准则提出了根据建议分级提出的14项建议,评估,发展,和评估方法,并由多学科专家审查。该指南提供了有用的信息,可以帮助内窥镜医师管理需要诊断性和选择性治疗性内窥镜检查的抗血栓药物患者。它将根据需要进行修改,以涵盖技术的变化,证据,或临床实践的其他方面。
Antithrombotic agents, including antiplatelet agent and
anticoagulants are widely used in Korea due to increasing incidence of cardio-cerebrovascular disease and aging population. The management of patients using antithrombotic agents during endoscopic procedures is an important clinical challenge. Clinical practice guideline regarding this issue which was developed by the Korean Society of Gastrointestinal Endoscopy was published in 2020. However, since then, new evidence has emerged for the use of dual antiplatelet therapy and direct anticoagulant management, and revised
guidelines were issued in the US and Europe. Accordingly, the previous
guidelines were revised, cardiologists also participated in the development group, and the recommendations went through a
consensus process among international experts. This guideline presents 14 recommendations made according to the Grading of Recommendations, Assessment, Development, and Evaluation methodology, and was reviewed by multidisciplinary experts. This
guideline provides useful information that can assist endoscopists in the management of patients on antithrombotic agents who require diagnostic and elective therapeutic endoscopy. It will be revised as necessary to cover changes in technology, evidence, or other aspects of clinical practice.